Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico. - Wikidata - awgldk - TriplyDB

Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.

Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.

http://www.wikidata.org/entity/Q35007651

about

Family history of breast and ovarian cancer and triple negative subtype in hispanic/latina women.Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients State of Art of Cancer Pharmacogenomics in Latin American Populations.Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru.The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer Unique Features of Germline Variation in Five Egyptian Familial Breast Cancer Families Revealed by Exome Sequencing.The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients.Genomic Disparities in Breast Cancer Among Latinas.Hereditary cancer syndromes in Latino populations: genetic characterization and surveillance guidelines.Characteristics of BRCA1/2 mutations carriers including large genomic rearrangements in high risk breast cancer patients Spectrum of BRCA1/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practice Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer.Impact of germline and somatic BRCA1/2 mutations: tumor spectrum and detection platforms.BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile.Mutations in context: implications of BRCA testing in diverse populations.A multi-gene panel study in hereditary breast and ovarian cancer in Colombia.Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations.Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations.Genetics of breast cancer in African populations: a literature review A novel method to detect the Mexican founder mutation BRCA1 ex9‑12del associated with breast and ovarian cancer using quantitative polymerase chain reaction and TaqMan® probes Description of Genetic Variants in Genes in Mexican Patients with Ovarian Cancer: A First Step towards Implementing Personalized Medicine Data mining of digitized health records in a resource-constrained setting reveals that timely immunophenotyping is associated with improved breast cancer outcomes

P2860

Q30620701-BC58911F-3AC2-4831-AD5D-BAEDAD59DC2A Q33618262-DCDD8ED9-5024-4CE2-905F-3E41CA83654E Q33838298-EE798781-E3E4-4296-895E-06C384DE587F Q33875862-E8FC8F33-0E28-4293-A8FB-14972B00134D Q34530426-D783E004-BDBB-4B77-B86E-545A9DD6BDBB Q35217775-A5D6F948-5F75-426E-8808-4AC729021CFD Q35940364-904E8BD3-011C-4130-A1DD-265EC628235E Q36246433-732CAEA0-6100-4ACA-A503-B7F6A380C1C9 Q36322846-39644419-D8F8-49E5-9516-E08AE64F704A Q36962696-6C7FA38D-89DE-4A9F-9DA5-F5135B1515E5 Q37509093-C3368EFD-BBB1-4D15-A915-EFD97B7DBBC5 Q37597246-C039674E-1B41-47F1-BB53-2A83CEBC3C53 Q37746872-75706DC1-FFBB-4A25-A0DB-43621F473959 Q41694365-A07EB6C6-594A-46D6-A1B9-347889989059 Q41696477-63E01197-449C-46A8-8F14-2D73A467D43B Q45870377-9D11113D-6F5C-45BD-B9E0-BD7A327ACC14 Q46009526-E6E81577-24D1-41E6-8DB8-11934FD21F44 Q47691368-817E4C75-E865-4558-AFB7-09783E82C58C Q48118231-974F796C-EB55-4AF6-9A3E-0D872AC7C5D9 Q49024646-5602C300-AFA3-4D0C-8371-A082C49E60CC Q49553408-F5D204DB-A148-4E9B-A300-8C68FAAC9790 Q57112866-25D4F92A-C0ED-40CD-B244-0EE9E535DDD3 Q57173171-AF31301D-8140-4755-8C51-0DCB743F328B Q58795187-9BD224B3-957D-411D-BE47-D82EEBB99162 Q59128695-A107D81C-CB3B-48CE-A57F-7701AB883C0E

P2860

Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.

http://www.wikidata.org/entity/Q35007651

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.

@ast

Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.

@en

type

label

Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.

@ast

Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.

@en

prefLabel

Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.

@ast

Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.

@en

P1433

Q35007651-B5DDCC2F-20A7-45EC-8F35-EA952B611269

P1476

Q35007651-FEA7ECEA-7130-4A42-AE1A-FFD9BA85FAF9

P2093

Q35007651-04E48EFD-36A9-444D-9114-0223E86FF6CF

Q35007651-0944D1B8-513A-48DA-8ADD-8011BACEE048

Q35007651-0CD1C9C4-097D-4752-9E5E-9A82C17F3740

Q35007651-0DAC350B-2D19-46CF-8FBD-94FD1576F524

Q35007651-264EC064-EE36-433D-BE14-0D556B5C4FFD

Q35007651-2F390EDD-067D-46F8-9937-A441AAD6EBCB

Q35007651-46C03040-462D-42B1-ABEE-97D34F8AB3FE

Q35007651-5761E421-2DDB-4583-8D75-137D488C5798

Q35007651-7D4769BC-827E-452A-900F-053675CF5700

Q35007651-B72215F3-FA0F-4570-9C0C-1440EE1A32C0

P2860

Q35007651-068E7136-06BF-45A8-9ECB-8643EA66CFC8

Q35007651-08AF340C-25BA-4036-B3FE-614CCD9EB36D

Q35007651-0AFD758A-E2A3-4477-93F8-BAA392A97554

Q35007651-0FE0AF72-4A5A-4F55-B853-00032D78BB60

Q35007651-1181A647-C042-4601-A781-9282654E9E7F

Q35007651-15B4C1B0-86B8-4AA7-9796-D57920832E77

Q35007651-166FC3CF-31DD-4400-AEF1-547C8EFCBB64

Q35007651-4241627A-C373-434F-BEAB-633F1D211C77

Q35007651-4D5C497E-D7D9-486F-ABFC-4CD396DA05ED

Q35007651-4D858851-2F6D-4296-930A-A2FE6423D7D5

P304

Q35007651-13C96744-016B-420F-BAC2-4F64454B7BD0

P31

Q35007651-808C8806-EBF2-4472-BD4F-C07FA68D33FF

P356

Q35007651-65002B6B-3260-488A-A40F-B8EB5D544C10

P407

Q35007651-E713C353-C2F9-412C-8A32-6772CDB4CA66

P433

Q35007651-0B61D3F1-FA22-41AD-8130-6DC819B68D41

P478

Q35007651-09C1C57E-4D54-4C71-B940-B5AE7BB0AF26

P50

Q35007651-B98B7466-6C4E-4608-BA5B-692F5759B7A8

Q35007651-F217C22A-5A74-44D4-AF44-D3B460B8812C

P577

Q35007651-B41B02D0-C213-4530-B0FD-12D7C32675F8

P5875

Q35007651-DAAFF822-AC1D-4A0D-93C6-32E4937F8B06

P698

Q35007651-72FF083F-77EA-4BB6-ADC8-BE921B1DF3CA

P932

Q35007651-FAEDFDDC-1893-4792-ADF8-C6437B0ECB77

P356

P1433

P1476

Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.

@en

P2093

Alejandro Mohar

http://www.w3.org/2001/XMLSchema#string

Clementina Castro

http://www.w3.org/2001/XMLSchema#string

Cynthia Villarreal-Garza

http://www.w3.org/2001/XMLSchema#string

Danielle Castillo

http://www.w3.org/2001/XMLSchema#string

Dolores Gallardo

http://www.w3.org/2001/XMLSchema#string

Jeffrey N Weitzel

http://www.w3.org/2001/XMLSchema#string

Josef Herzog

http://www.w3.org/2001/XMLSchema#string

Kathleen R Blazer

http://www.w3.org/2001/XMLSchema#string

Lenny N Gallardo

http://www.w3.org/2001/XMLSchema#string

Luis A Herrera

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer.

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer

Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America.

Prevalence of BRCA mutations and founder effect in high-risk Hispanic families.

P304

372-378

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.29058

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Carlos Pérez-Plasencia

Miguel Santibáñez

P577

2014-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265789584

http://www.w3.org/2001/XMLSchema#string

P698

25236687

http://www.w3.org/2001/XMLSchema#string

P932

4304938

http://www.w3.org/2001/XMLSchema#string